Explore the U.S. patents Merck deploys to stymie competition and keep revenues for its blockbuster cancer drug flowing as ...
The main market opportunities include mastering complex US patent practices to improve collaboration with US counterparts, optimizing prosecution strategy, and understanding key legal nuances between ...
Pangea Pharmaceuticals, a U.S.-based, patient-centered pharmaceutical company focused on bringing differentiated, clinically relevant products to market, today announced the U.S.
Patent-pending Positioning System and AI Adoption Indexes deliver the broadband industry’s first quantitative AI benchmarks and turn-by-turn adoption guidance ...
In addition to its supercycle growth-equity ETFs, VistaShares has launched its “Legends + Income” suite, which allow investors to mimic the publicly-available equity portfolios of some of the world’s ...
Forget worldly woes for a few minutes and gawk at these spectacular and mind-bogglingly spendy timepieces we saw in Geneva.
Detailed price information for Lexaria Bioscience Corp (LEXX-Q) from The Globe and Mail including charting and trades.
An expert explains how to choose the sexiest cultivated varieties of native plants that will also deliver the best ecological ...
DSS, Inc. (NYSE American: DSS) today issued the following letter to shareholders from the Interim CEO, Jason Grady , highlighting the Company’s operational progress, financial improvements, and ...
TAP, Inc., a financial technology company focused on multi-asset investing, payments, and blockchain-based financial markets technologies, today announced the launch of the TAP Terminal, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results